Use of a biochip assaying 28 mutations in the KRAS, BRAF, TP53, and APC genes for detection of colorectal neoplasia

被引：1
|
作者：
Hughes, D. [1 ]
O'Morain, C. [1 ]
Lee, N. [1 ]
Kelley, L. [1 ]
McMurray, H. [2 ]
Latten, M. [2 ]
Ebert, M. [3 ]
机构：
[1] AMNCH Hosp, Trinity Coll Dublin, Dept Clin Med, Dublin, Ireland
[2] Randox Labs, DNA Diagnost, Crumlin, Ireland
[3] Tech Univ Munich, Munich, Germany
来源：
EJC SUPPLEMENTS | 2010年 / 8卷 / 05期
关键词：
D O I：
10.1016/S1359-6349(10)70936-8
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
128
引用
收藏
页码：33 / 34
页数：3
相关论文
共 50 条
  • [21] Hotspot mutations of TP53 sensitize APC-mutated colorectal cancer cells to cetuximab in vitro
    Yang, Mingli
    Wang, Heiman
    Davis, Thomas B.
    Pflieger, Lance
    Thota, Ramya
    Pledger, W. Jack
    Yeatman, Timothy J.
    CANCER RESEARCH, 2022, 82 (12)
  • [22] TP53 mutations in colorectal cancer from Tunisia: relationships with site of tumor origin, microsatellite instability and KRAS mutations
    Aissi, Sana
    Buisine, Marie-Pierre
    Zerimech, Farid
    Kourda, Nadia
    Moussa, Amel
    Manai, Mohamed
    Porchet, Nicole
    MOLECULAR BIOLOGY REPORTS, 2014, 41 (03) : 1807 - 1813
  • [23] TP53 mutations in colorectal cancer from Tunisia: relationships with site of tumor origin, microsatellite instability and KRAS mutations
    Sana Aissi
    Marie-Pierre Buisine
    Farid Zerimech
    Nadia Kourda
    Amel Moussa
    Mohamed Manai
    Nicole Porchet
    Molecular Biology Reports, 2014, 41 : 1807 - 1813
  • [24] KRAS mutations in colorectal cancer from Tunisia: relationships with clinicopathologic variables and data on TP53 mutations and microsatellite instability
    Sana Aissi
    Marie-Pierre Buisine
    Farid Zerimech
    Nadia Kourda
    Amel Moussa
    Mohamed Manai
    Nicole Porchet
    Molecular Biology Reports, 2013, 40 : 6107 - 6112
  • [25] KRAS mutations in colorectal cancer from Tunisia: relationships with clinicopathologic variables and data on TP53 mutations and microsatellite instability
    Aissi, Sana
    Buisine, Marie-Pierre
    Zerimech, Farid
    Kourda, Nadia
    Moussa, Amel
    Manai, Mohamed
    Porchet, Nicole
    MOLECULAR BIOLOGY REPORTS, 2013, 40 (11) : 6107 - 6112
  • [26] Prevalence and coexistence of KRAS, BRAF, PIK3CA, NRAS, TP53, and APC mutations in Indian colorectal cancer patients: Next-generation sequencing-based cohort study
    Jauhri, Mayank
    Bhatnagar, Akanksha
    Gupta, Satish
    Bp, Manasa
    Minhas, Sachin
    Shokeen, Yogender
    Aggarwal, Shyam
    TUMOR BIOLOGY, 2017, 39 (02)
  • [27] Yolk Sac Tumor in a Recurrence of Colonic Adenocarcinoma With Shared Mutations in APC and TP53 Genes: A Case Report
    Otani, Tomoyuki
    Kanemura, Hiroaki
    Kimura, Masatomo
    Mitani, Seiichiro
    Takeda, Masayuki
    Matsuki, Mitsuru
    Matsumura, Noriomi
    Satou, Takao
    Nakagawa, Kazuhiko
    Ito, Akihiko
    INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY, 2022, 30 (06) : 646 - 651
  • [28] KRAS and TP53 mutations in inflammatory bowel disease-associated colorectal cancer: a meta-analysis
    Du, Lijun
    Kim, John J.
    Shen, Jinhua
    Chen, Binrui
    Dai, Ning
    ONCOTARGET, 2017, 8 (13) : 22175 - 22186
  • [29] Simultaneous detection of KRAS and TP53 mutations in human cancer cell lines using multiplex qPCR
    Patel, Sunali
    Woo, Cora
    Wilde, Joyce
    Phanse, Sundiep
    CANCER RESEARCH, 2014, 74 (19)
  • [30] Detection of TP53 Mutations in the Peritoneal Washings of Women with Germline Mutations in Ovarian Cancer Susceptibility Genes
    Goebel, Emily
    Qian, Xiaohua
    Xie, Jingzhong
    Chapel, David
    Hill, Sarah
    Garber, Judy
    Xian, Wa
    Crum, Christopher
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 1063 - 1064
12345